Physiologic Concentrations of Bile Salts Inhibit Rat Hepatic Alkaline Phosphatase but Not the Intestinal Isoenzyme (original) (raw)

Abstract

The effect of bile salts on alkaline phosphatase (EC 3.1.3.1) activity from Wistar rat liver, duodenum, jejunum, and serum was investigated. Design and results: For concentrations higher than 1 mM conjugated bile salts (glycocholate, glycochenodeoxycholate, taurocholate, taurodeoxycholate, and taurochenodeoxycholate) inhibited hepatic ALP but, up to concentrations of 10 mM, had no effect on intestinal ALP. Also cholate, deoxycholate, and chenodeoxycholate, within the same concentration range, did not have any effect on intestinal ALP. ALP inhibition induced by conjugated bile salts was significantly higher in serum of starved rats than in serum of fed animals, what is in good agreement with the known higher proportion of hepatic ALP and lower proportion of intestinal ALP in serum of starved rats. Conclusions: Bile salts can, thus, be used to help discriminating between tissue-nonspecific and intestinal ALP isoenzymes and identifying pathologic conditions where the relative quantities of these isoenzymes are altered in serum. Inhibition of hepatic ALP by physiologic concentrations of bile salts may bear some relation to the bile salts effects on their own enterohepatic circulation and/or biosynthesis.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (49)

  1. Van Hoof VO, De Broe ME. Interpretation and clinical significance of alkaline phosphatase isoenzyme pat- terns. Crit Rev Clin Lab Sci 1994; 31: 197-293.
  2. Alpers DH, Eliakim R, DeSchryver-Kecskemeti K. Secretion of hepatic and intestinal alkaline phospha- tases: similarities and differences. Clin Chim Acta 1989; 186: 211-24.
  3. Hamilton BA, McPhee JL, Hawrylak K, Stinson RA. Alkaline phosphatase releasing activity in human tissues. Clin Chim Acta 1989; 186: 249 -54.
  4. Deng JT, Hoylaerts MF, Van Hoof VO, De Broe ME. Differential release of human intestinal alkaline phosphatase in duodenal fluid and serum. Clin Chem 1992; 38: 2532-8.
  5. Moss DW. Release of membrane-bound enzymes from cells and the generation of isoforms. Clin Chim Acta 1994; 226: 131-42.
  6. Raymond FD, Moss DW, Fisher D. Separation of alkaline phosphatase isoforms with and without in- tact glycan-phosphatidylinositol anchors in aqueous polymer phase systems. Clin Chim Acta 1994; 227: 111-20.
  7. Deng JT, Hoylaerts MF, Nouwen EJ, De Broe ME, Van Hoof VO. Purification of circulating liver plasma mem- brane fragments using a monoclonal antileucine amino- peptidase antibody. Hepatology 1996; 23: 445-54.
  8. Van Hoof VO, Deng JT, De Broe ME. How do plasma membranes reach the circulation? Clin Chim Acta 1997; 266: 23-31.
  9. Crofton PM. Biochemistry of alkaline phosphatase isoenzymes. Crit Rev Clin Lab Sci 1982; 16: 160 -94.
  10. Calhau C, Hipo ´lito-Reis C, Azevedo I. Alkaline phos- phatase and exchange surfaces. Clin Biochem 1999; 32: 153-4.
  11. Martel F, Martins MJ, Hipo ´lito-Reis C, Azevedo I. Inward transport of [ 3 H]-1-methyl-4-phenylpyri- dinium in rat isolated hepatocytes: putative involve- ment of a P-glycoprotein transporter. Br J Pharmacol 1996; 119: 1519 -24.
  12. Martel F, Martins MJ, Calhau C, Hipo ´lito-Reis C, Azevedo I. Postnatal development of organic cation transport in the rat liver. Pharmacol Res 1998; 37: 131-6.
  13. Hofmann AF, Small DM. Detergent properties of bile salts: correlation with physiological function. Annu Rev Med 1967; 18: 333-76.
  14. Coleman R. Bile salts and biliary lipids. Biochem Soc Trans 1987; 15: 68 -80S.
  15. Brunton LL. Agents affecting gastrointestinal water flux and motibility, digestants, and bile acids. In:
  16. Gilman AG, Rall TW, Nies AS, Taylor P, Eds. The pharmacological basis of therapeutics. Pp. 914 -32, 8th ed. New York: Pergamon Press, 1990.
  17. Coleman R, Holdsworth G. The release of membrane components prior to haemolysis during extraction of intact erythrocytes with bile salts. Biochim Biophys Acta 1976; 426: 776 -80.
  18. Vyvoda OS, Coleman R, Holdsworth G. Effects of differ- ent bile salts upon the composition and morphology of a liver plasma membrane preparation. Deoxycholate is more membrane damaging than cholate and its conju- gates. Biochim Biophys Acta 1977; 465: 68 -76.
  19. Billington D, Evans CE, Godfrey PP, Coleman R. Effects of bile salts on the plasma membranes of isolated rat hepatocytes. Biochem J 1980; 188: 321-7.
  20. Coleman R, Iqbal S, Godfrey PP, Billington D. Mem- branes and bile formation. Composition of several mammalian biles and their membrane-damaging properties. Biochem J 1979; 178: 201-8.
  21. Attili AF, Angelico M, Cantafora A, Alvaro D, Capoc- accia L. Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids. Med Hypotheses 1986; 19: 57-69.
  22. Sung JY, Shaffer EA, Costerton JW. Antibacterial activity of bile salts against common biliary patho- gens. Effects of hydrophobicity of the molecule and in the presence of phospholipids. Dig Dis Sci 1993; 38: 2104 -12.
  23. Shiozaki H, Yoshioka M, Miura S, et al. Conjugated bile salts regulate turnover of rat intestinal brush border membrane hydrolases. Dig Dis Sci 1995; 40: 1193-8.
  24. Heuman DM, Pandak WM, Hylemon PB, Vlahceciv ZR. Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and human erythrocytes. Hepatology 1991; 14: 920 -6.
  25. Coleman R, Lowe P. Membrane damage caused by bile salts. Biochem Soc Trans 1980; 8: 126 -7.
  26. Ilani A, Granoth R. The pH dependence of the hemo- lytic potency of bile salts. Biochim Biophys Acta 1990; 1027: 199 -204.
  27. Morgan WA, Kaler B, Bach PH. The effects of bile salts on the kinetic properties of enzymes used in the diagnosis of liver and kidney damage. Biochem Soc Trans 1997; 25: 76S.
  28. Morgan WA, Sharma P, Kaler B, Bach PH. The modulation of protein kinase C by bile salts. Biochem Soc Trans 1997; 25: 75S.
  29. Beuers U. Effects of bile acids on hepatocellular sig- naling and secretion. Yale J Biol Med 1997; 70: 341-6.
  30. Beuers U, Probst I, Soroka C, Boyer JL, Kullak- Ublick G-A, Paumgartner G. Modulation of protein kinase C by taurolithocholic acid in isolated rat hepa- tocytes. Hepatology 1999; 29: 477-82.
  31. Makishima M, Okamoto AY, Repa JJ, et al. Identifi- cation of a nuclear receptor for bile acids. Science 1999; 284: 1362-8.
  32. Martins MJ, Dias PO, Hipo ´lito-Reis C. Rat serum alkaline phosphatase electrophoretic fractions: varia- tions with feeding, starvation and cellulose fibre in- gestion. Clin Nutr 1998; 17: 279 -85.
  33. Glickman RM, Alpers DH, Drummey GD, Isselbacher KJ. Increased lymph alkaline phosphatase after fat feeding: effects of medium chain triglycerides and inhibition of protein synthesis. Biochim Biophys Acta 1970; 201: 226 -35.
  34. Young GP, Friedman S, Yedlin ST, Alpers DH. Effect of fat feeding on intestinal alkaline phosphatase ac- tivity in tissue and serum. Am J Physiol 1981; 241: G461-8.
  35. Martins MJ, Negra ˜o MR, Hipo ´lito-Reis C. Effect of bile salts on serum alkaline phosphatase activity from starved and fed rats. Ital Biochem Soc Trans 1999; 13: 256.
  36. Martins MJ, Negra ˜o MR, Hipo ´lito-Reis C. Effect of bile salts on rat hepatic and intestinal alkaline phos- phatase. Ital Biochem Soc Trans 1999; 13: 257.
  37. Hipo ´lito-Reis C, Dias PO, Martins MJ. Importance of assay conditions in visualization and quantitation of serum alkaline phosphatase isoenzymes separated by electrophoresis. Scand J Clin Lab Invest 1999; 59: 593-606.
  38. Fernley HN. Mammalian alkaline phosphatases. In: Boyer PD, Ed. The enzymes, Vol. IV. Pp. 417-47. New York: Academic Press, 1971.
  39. Israeli B-A, Bogin E. Biochemical changes in liver, kidney and blood associated with common bile duct ligation. Clin Chim Acta 1986; 160: 211-21.
  40. Hepner GW, Hofmann AF. Different effects of free and conjugated bile acids and their keto derivatives on (Na ϩ ,K ϩ )-stimulated and Mg 2ϩ -ATPase of rat intestinal mucosa. Biochim Biophys Acta 1973; 291: 237-45.
  41. Miki A, Tanaka Y, Ogata S, Ikehara Y. Selective preparation and characterization of membranous and soluble forms of alkaline phosphatase from rat tis- sues. A comparison with the serum enzyme. Eur J Biochem 1986; 160: 41-8.
  42. Miura S, Yoshioka M, Hamada Y, Morita A, Asakura H, Tsuchiya M. Alkaline phosphatase of rat intestinal lymph: its characterization and the effect of fat ad- ministration. Clin Chim Acta 1989; 186: 239 -48.
  43. McComb RB, Bowers GN, Posen S. Alkaline phospha- tase. Pp. 289 -372. New York: Plenum Press, 1979.
  44. Fishman WH, Sie H-G. Organ-specific inhibition of human alkaline phosphatase isoenzymes of liver, bone, intestine and placenta; L-phenylalanine, L-tryptophan and L-homoarginine. Enzymologia 1971; 41: 141-67.
  45. Armstrong MJ, Carey MC. The hydrophobic-hydro- philic balance of bile salts. Inverse correlation be- tween reverse-phase high performance liquid chro- matographic mobilities and micellar cholesterol- solubilizing capacities. J Lipid Res 1982; 23: 70 -80.
  46. Luker GD, Nilsson KR, Covey DF, Piwnica-Worms D. Multidrug resistance (MDR1) P-glycoprotein en- hances esterification of plasma membrane cholesterol. J Biol Chem 1999; 274: 6979 -91.
  47. Metherall JE, Li H, Waugh K. Role of multidrug resistance P-glycoproteins in cholesterol biosynthesis. J Biol Chem 1996; 271: 2634 -40.
  48. Field FJ, Born E, Murthy S, Mathur SN. Transport of cholesterol from the endoplasmic reticulum to the plasma membrane is constitutive in CaCo-2 cells and differs from the transport of plasma membrane cho- lesterol to the endoplasmic reticulum. J Lipid Res 1998; 39: 333-43.
  49. Debry P, Nash EA, Neklason DW, Metherall JE. Role of multidrug resistance P-glycoproteins in cholesterol esterification. J Biol Chem 1997; 272: 1026 -31.